Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 242 entries
View as:

Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations

Phase: N/A Priority: Normal
NCT ID: NCT01338896 Org: User:
Start: 04/30/11 End: 06/30/11 Due: 06/30/12

Study of Epratuzumab in Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT00383513 Org: User:
Start: 06/30/06 End: 01/31/12 Due: 01/31/13

Trial to Assess Efficacy and Safety of Lacosamide in Subjects With Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT00485472 Org: User:
Start: 03/31/07 End: 01/31/08 Due: 01/31/09

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults

Phase: N/A Priority: Normal
NCT ID: NCT00368251 Org: User:
Start: 11/30/06 End: 01/31/08 Due: 01/31/09

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Phase: N/A Priority: Normal
NCT ID: NCT00220415 Org: User:
Start: 05/31/04 End: 01/31/06 Due: 01/31/07

A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00139867 Org: User:
Start: 01/31/04 End: 05/31/04 Due: 05/31/05

Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.

Phase: N/A Priority: Normal
NCT ID: NCT00150787 Org: User:
Start: 07/31/03 End: 11/30/05 Due: 11/30/06

A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)

Phase: N/A Priority: Normal
NCT ID: NCT00160511 Org: User:
Start: 04/30/04 End: 09/30/05 Due: 09/30/06

A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis

Phase: N/A Priority: Normal
NCT ID: NCT00139893 Org: User:
Start: 06/30/05 End: - Due: -

Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT00544050 Org: User:
Start: 09/30/02 End: 05/31/03 Due: 05/31/04

A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00139789 Org: User:
Start: 01/31/05 End: 04/30/05 Due: 04/30/06

Dosing Flexibility Study in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00580840 Org: User:
Start: 12/31/07 End: 03/31/11 Due: 03/31/12

A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00422110 Org: User:
Start: 05/31/08 End: - Due: -

Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00175916 Org: User:
Start: 09/30/05 End: 05/31/19 Due: 05/31/20

Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT01235598 Org: User:
Start: 12/31/10 End: 05/31/13 Due: 05/31/14

LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)

Phase: N/A Priority: Normal
NCT ID: NCT00160589 Org: User:
Start: 04/30/05 End: 09/30/05 Due: 09/30/06

Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00771927 Org: User:
Start: 10/31/08 End: 03/31/12 Due: 03/31/13

Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol

Phase: N/A Priority: Normal
NCT ID: NCT01190410 Org: User:
Start: 08/31/10 End: 11/27/17 Due: 11/27/18

A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT00440518 Org: User:
Start: 02/28/07 End: 07/31/08 Due: 07/31/09

A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00175877 Org: User:
Start: 06/30/05 End: 02/29/12 Due: 02/28/13

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01521923 Org: User:
Start: 01/31/12 End: 09/30/15 Due: 09/30/16

Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab

Phase: N/A Priority: Normal
NCT ID: NCT00307931 Org: User:
Start: 04/30/07 End: 08/31/08 Due: 08/31/09

Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)

Phase: N/A Priority: Normal
NCT ID: NCT00160563 Org: User:
Start: 06/30/04 End: 03/31/06 Due: 03/31/07

Quality of Life and Adverse Effects in Epilepsy Patients (EPIKA)

Phase: N/A Priority: Normal
NCT ID: NCT00302991 Org: User:
Start: 03/31/06 End: 10/31/07 Due: 10/31/08

Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional Study

Phase: N/A Priority: Normal
NCT ID: NCT00598780 Org: User:
Start: 09/30/07 End: 09/30/08 Due: 09/30/09